AVENTIS PASTEUR S A has a total of 17 patent applications. Its first patent ever was published in 1993. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and macromolecular chemistry and polymers are HOOKIPA BIOTECH GMBH, BIONDVAX PHARMACEUTICALS LTD and LISZIEWICZ JULIANNA.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 14 | |
#2 | Australia | 1 | |
#3 | EPO (European Patent Office) | 1 | |
#4 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Macromolecular chemistry and polymers | |
#4 | Machines | |
#5 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Polysaccharides | |
#6 | Shaping of plastics | |
#7 | Unspecified technologies | |
#8 | Climate change adaptation technologies | |
#9 | Microbiology |
# | Name | Total Patents |
---|---|---|
#1 | Chevalier Michel | 6 |
#2 | El Habib Raphaelle | 4 |
#3 | Sodoyer Regis | 3 |
#4 | Moreau Monique | 3 |
#5 | Krell Tino | 3 |
#6 | Haensler Jean | 2 |
#7 | Klein Michel | 2 |
#8 | Ho David | 2 |
#9 | Markowitz Martin | 2 |
#10 | Mistretta Noelle | 2 |
Publication | Filing date | Title |
---|---|---|
US2004170638A1 | Conjugates obtained by reductive amination of the pneumococcus serotype 5 capsular polysaccharide | |
US7056519B2 | Methods for inducing HIV-neutralizing antibodies | |
US6861253B2 | Polypeptide inducing antibodies neutralizing HIV | |
WO0154701A1 | Vaccination of hiv infected persons following highly active antiretroviral therapy | |
US6664049B1 | Method and device for cell lysis |